RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-4646
Malaria parasiteP. berghei
Genotype
DisruptedGene model (rodent): PBANKA_1002500; Gene model (P.falciparum): PF3D7_0404800; Gene product: conserved Plasmodium protein, unknown function (PbS10)
Transgene
 Transgene not Plasmodium: GFP
Promoter: Gene model: PBANKA_0711900; Gene model (P.falciparum): PF3D7_0818900; Gene product: heat shock protein 70 (HSP70)
3'UTR: Gene model: PBANKA_0711900; Gene product: heat shock protein 70 (HSP70)
Insertion locus: Gene model: PBANKA_1002500; Gene product: conserved Plasmodium protein, unknown function (PbS10)
Phenotype Sporozoite; Liver stage;
Last modified: 3 July 2019, 12:19
  *RMgm-4646
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene disruption, Introduction of a transgene
Reference (PubMed-PMID number) Reference 1 (PMID number) : 31251952
MR4 number
top of page
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
top of page
The mutant parasite was generated by
Name PI/ResearcherTogiri J, Kumar KA
Name Group/DepartmentDepartment of Animal Biology, School of Life Sciences
Name InstituteUniversity of Hyderabad
CityHyderabad
CountryIndia
top of page
Name of the mutant parasite
RMgm numberRMgm-4646
Principal namePbS10 GD
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
top of page
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystNot different from wild type
SporozoiteProduction of salivary gland sporozoites comparable to wild type. Normal sporozoite gliding motility, cell traversal and hepatocyte infection in vitro.
Liver stageNormal sporozoite gliding motility, cell traversal and hepatocyte infection in vitro. PbS10 GD mutants manifested no defect in their growth until 12 h time point. However, beyond this time point ie., at 36 h PbS10 GD mutants did not show any appreciable growth as compared to wild type parasites. (Strongly) reduced infectivity in vivo (no blood infections or prolonged period after intravenous injection of sporozoites or after mosquito bite).
Additional remarks phenotype

Mutant/mutation
The mutant lacks expression of Pbs10 and expresses GFP under control of the constitutive hsp70 promoter

Protein (function)
PbS10 was identified in SSH screen between salivary gland sporozoites versus merozoites and encode secretory protein having a predicted molecular mass of 66.7 kDa and a putative signal peptide.

Phenotype
Production of salivary gland sporozoites comparable to wild type. Normal sporozoite gliding motility, cell traversal and hepatocyte infection in vitro. PbS10 GD mutants manifested no defect in their growth until 12 h time point. However, beyond this time point ie., at 36 h PbS10 GD mutants did not show any appreciable growth as compared to wild type parasites. (Strongly) reduced infectivity in vivo (no blood infections or prolonged prepatent period after intravenous injection of sporozoites or after mosquito bite).

Additional information
Quantitative real-time PCR analysis revealed maximal expression of PbS10 in midgut oocyst stages followed by salivary gland sporozoite stage. The expression of PbS10 was minimal during different time points of liver stage development and in mixed blood stages.

Other mutants

  Disrupted: Mutant parasite with a disrupted gene
top of page
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1002500
Gene Model P. falciparum ortholog PF3D7_0404800
Gene productconserved Plasmodium protein, unknown function
Gene product: Alternative namePbS10
top of page
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct used(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Partial or complete disruption of the geneComplete
Additional remarks partial/complete disruption
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationFor the generation of PbS10 gene disruption
construct, two homology fragments 5’ (507 bp) and 3’ (530 bp) were amplified using primer pairs FP1/RP1 and FP2/RP2 respectively. 5’ and 3’ fragments were cloned into pBC-GFP-hDHFR vector at XhoI/ClaI and NotI/AscI respectively. The targeting construct was released by XhoI and AscI digestion and gel purified
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6
top of page
  Transgene: Mutant parasite expressing a transgene
top of page
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameGFP
top of page
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modification
Additional remarks selection procedure
top of page
Other details transgene
top of page
Promoter
Gene Model of Parasite PBANKA_0711900
Gene Model P. falciparum ortholog PF3D7_0818900
Gene productheat shock protein 70
Gene product: Alternative nameHSP70
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
top of page
3'-UTR
Gene Model of Parasite PBANKA_0711900
Gene productheat shock protein 70
Gene product: Alternative nameHSP70
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionInsertion locus
Gene Model of Parasite PBANKA_1002500
Gene productconserved Plasmodium protein, unknown function
Gene product: Alternative namePbS10
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
top of page
Conceptual design of the database: Dr. C.J. Janse (Leiden Malaria Research Group, Leiden, The Netherlands).
Technical design and realization: S. Mededovic and A. van Wigcheren